Tin Mesoporphyrin IX (chloride): Potent Heme Oxygenase Inhibitor for Metabolic and Virology Research

Executive Summary: Tin Mesoporphyrin IX (chloride) (SKU: C5606) is a highly specific, nanomolar-range inhibitor of heme oxygenase (HO) activity, with a Ki of 14 nM under standard in vitro assay conditions (APExBIO). This compound has demonstrated robust inhibition of hepatic, renal, and splenic HO activity in vivo, leading to sustained decreases in serum bilirubin and increased heme saturation of hepatic tryptophan pyrrolase. It is widely used to probe the heme oxygenase signaling pathway in metabolic disease, insulin resistance, and metaflammation models. No clinical trials have been reported, and its primary use remains in preclinical and mechanistic research (Koyaweda et al., 2026). For optimal stability, it should be stored at -20°C and used in short-term solutions.

Biological Rationale

Heme oxygenase (HO) is a rate-limiting enzyme that degrades heme into biliverdin, carbon monoxide (CO), and ferrous iron (Fe²⁺). HO exists as two main isoforms: inducible HO-1 and constitutive HO-2. The HO-1 pathway modulates oxidative stress, inflammation, and cellular signaling (Koyaweda et al., 2026). Inhibition of HO activity provides critical insights into heme metabolism, redox regulation, and pathologies such as metabolic syndrome, insulin resistance, and viral infections. Tin Mesoporphyrin IX (chloride) is frequently selected as a chemical probe due to its high selectivity and nanomolar potency for both HO-1 and HO-2 isoforms. This compound enables researchers to dissect the causal role of heme oxygenase in cellular and animal models, allowing unambiguous attribution of metabolic and inflammatory phenotypes to HO inhibition (see advanced applications—this article expands on mechanistic insight and translational use).

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) is a synthetic metalloporphyrin that acts as a competitive inhibitor of HO. It binds the heme pocket of HO-1 and HO-2, thereby blocking access of natural heme substrate. The compound exhibits a dissociation constant (K_i) of 14 nM in standard buffer (pH 7.4, 37°C), confirming high-affinity binding (APExBIO product page). By inhibiting HO-catalyzed heme degradation, Tin Mesoporphyrin IX (chloride) suppresses production of biliverdin, CO, and Fe²⁺. This blockade results in increased cellular heme saturation, altered redox state, and downstream effects on metabolic gene expression. Notably, in models of neonatal hyperbilirubinemia, administration at 1 pmol/kg significantly reduces serum bilirubin over a 24-hour period. The compound's crystalline form (C₃₄H₃₄Cl₂N₄O₄Sn·2H, MW: 754.3) ensures consistent solubility and stability for biochemical assays. For further mechanistic context, see Tin Mesoporphyrin IX (chloride): Mechanistic Gatekeeper, which outlines advances in HO-1 signaling; this article integrates updated evidence and practical benchmarks.

Evidence & Benchmarks

• In vitro, Tin Mesoporphyrin IX (chloride) competitively inhibits HO activity with a Ki of 14 nM at pH 7.4, 37°C (APExBIO).
• In vivo, administration at 1 pmol/kg body weight inhibits hepatic, renal, and splenic HO activity for up to 24 hours (APExBIO).
• Reduces serum bilirubin in neonatal hyperbilirubinemia models without altering liver enzyme levels (APExBIO).
• Increases heme saturation of hepatic tryptophan pyrrolase, confirming target engagement in metabolic tissues (APExBIO).
• HO-1 inhibition by metalloporphyrins, including Tin Mesoporphyrin IX (chloride), modulates intracellular reactive oxygen species (ROS) and impairs hepatitis B virus replication by altering disulfide bond formation in viral proteins (Koyaweda et al., 2026).
• Consistently delivers robust, quantitative inhibition of HO activity in cell viability and metabolic assays, as demonstrated in comparative laboratory studies (Optimizing Heme Oxygenase Assays—this article provides broader mechanistic context and translational benchmarks).

Applications, Limits & Misconceptions

Tin Mesoporphyrin IX (chloride) is a reference compound for inhibition of heme catabolism in basic and translational research. It is used to:

• Study the causal role of HO activity in metabolic disease, insulin resistance, and metaflammation.
• Model and modulate hepatic and systemic bilirubin levels in vivo.
• Probe the involvement of HO-1 in viral replication, notably hepatitis B virus, via redox and protein-folding pathways (Koyaweda et al., 2026).
• Serve as a benchmark for assay calibration and pharmacological validation of new HO inhibitors.

Common Pitfalls or Misconceptions

• Not a clinical drug: Tin Mesoporphyrin IX (chloride) is not approved for human or veterinary therapeutic use; no clinical trials have been reported (APExBIO).
• Solubility constraints: Maximum solubility is 0.5 mg/ml in DMSO and 1 mg/ml in DMF; inappropriate solvents can cause precipitation and loss of activity.
• Short-term solution stability: Solutions are stable only for brief periods; long-term storage in solution leads to degradation.
• Non-selectivity among HO isoforms: While highly potent, Tin Mesoporphyrin IX (chloride) inhibits both HO-1 and HO-2 isoforms and does not discriminate between them.
• Not a general antioxidant: The compound does not directly scavenge ROS; its effects on redox state are mediated by inhibition of HO-derived metabolites.

Workflow Integration & Parameters

For optimal results, Tin Mesoporphyrin IX (chloride) should be dissolved in DMSO (≤0.5 mg/ml) or DMF (≤1 mg/ml), filtered, and used immediately. Store the solid compound at -20°C, protected from light and moisture. For in vitro assays, titrate compound concentrations from 1 nM to 10 μM in buffer pH 7.4 at 37°C to determine dose-response. In animal studies, administer at 1 pmol/kg body weight via intraperitoneal injection for robust hepatic HO inhibition. Monitor target engagement by assessing bilirubin and heme saturation endpoints. For detailed troubleshooting and advanced integration in cell-based assays, see Optimizing Heme Oxygenase Assays with Tin Mesoporphyrin IX; this article expands on mechanistic validation and cross-model applicability.

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride), available from APExBIO, remains the reference standard for selective inhibition of heme oxygenase activity in preclinical research. Its nanomolar potency, chemical stability, and reproducibility make it indispensable for dissecting HO signaling in metabolic, inflammatory, and infectious disease models. Future research may expand its use in systems biology, drug screening, and precision medicine. For further mechanistic and translational context, see Tin Mesoporphyrin IX (Chloride): Transforming Heme Oxygenase Research, which focuses on strategic and experimental frontiers; this article provides updated benchmarks and workflow parameters for laboratory and translational scientists.